GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • WASHINGTON— Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients. The Food and Drug Administration approved the combination drug, Entresto, based on studies showing it reduced rates of heart-related death and hospitalization compared with older drugs.

  • Wild birds that spread the virus will very likely carry it when they begin migrating south in the fall, John Clifford, the USDA's chief veterinary officer, said in remarks prepared for a U.S. Senate Agriculture Committee hearing on Tuesday. Clifford testified before the Senate committee after U.S. lawmakers from Iowa criticized the USDA for taking too long to...

  • CENTENNIAL, Colo.— A second defense expert testified Tuesday that the Colorado theater shooter was so mentally ill that he couldn't tell right from wrong at the time he opened fire on a packed auditorium, killing 12 people and injuring 70.. James Holmes suffered from schizophrenia and delusions and met the legal definition of insanity at the time of the 2012...

  • First US death from this disease in over a decade Thursday, 2 Jul 2015 | 5:08 PM ET
    In this handout from the Centers for Disease Control and Prevention (CDC), a thin-section transmission electron micrograph (TEM) reveales the ultrastructural appearance of a single virus particle, or 'virion', of measles virus.

    A woman living in northwestern Washington has died from measles, according to state health officials, NBC News reports.

  • CHICAGO, July 2- An experimental Johnson& Johnson vaccine completely prevented HIV infection in half of monkeys that got the shot and then were exposed to high doses of an aggressive virus, results that spurred the company to test the vaccine in people, academic and company researchers said on Thursday. The international trial is underway in 400 healthy...

  • FDA clears drug for leading form of cystic fibrosis Thursday, 2 Jul 2015 | 12:22 PM ET

    WASHINGTON— Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will come at a steep price— more than $250,000 for a year's treatment. The Food and Drug Administration cleared the twice-a-day...

  • LONDON, July 2- Alarmed by rising resistance to antibiotics, the main line of defence against bacterial infections, scientists and governments are taking a fresh look at bacteria-chomping viruses first isolated a century ago from the stools of patients recovering from dysentery. So-called bacteriophages, which attack bacteria but leave human cells...

  • Watch a surgeon tattoo this man's eyeball

    A Harvard-trained eye surgeon demonstrates how to perform a corneal tattoo on a man with one blind, milky-white eye. It's a merging of medicine and body art that will help restore confidence and quality of life.

  • LONDON, July 2- China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai- based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient. The collaboration between GSK's HIV unit ViiV Healthcare and Desano marks an improvement in the business climate for the...

  • A cure for cancer? Wednesday, 1 Jul 2015 | 2:49 PM ET
    A cure for cancer?

    One of the world's leading cancer geneticist says its possible a cure for cancer will be found within the next 10 years, thanks to technology by Juno Therapeutics. Dr. Gary Gilliland of Fred Hutch Cancer Research, launched Juno in 2013.

  • NEW YORK, July 1- Two years after New York socialite Brooke Astor died in 2007, her son, Anthony Marshall, was convicted of bilking her of millions of dollars. Three states, most recently Missouri, have enacted laws that allow retail brokers to help curb scams against people with dementia. More than five million Americans over the age of 65 have Alzheimer's disease,...

  • NEW YORK, July 1- Two years after New York socialite Brooke Astor died in 2007, her son, Anthony Marshall, was convicted of bilking her of millions of dollars. Three states, most recently Missouri, have enacted laws that allow retail brokers to help curb scams against people with dementia. More than five million Americans over the age of 65 have Alzheimer's disease,...

  • ZURICH, June 30- A drug being developed by Roche to treat multiple sclerosis met its main targets in two final-stage clinical trials, boosting the Swiss company's hopes of expanding beyond its core cancer business. Rebif, made by Germany's Merck KGaA, is already battling stiff competition from a new generation of oral drugs against the debilitating disease.

  • June 29- Celgene Corp said it would invest about $1 billion in Juno Therapeutics Inc to partner in the development and marketing of immunotherapies for the treatment of cancer and autoimmune diseases. Celgene will pay Juno about $150 million upfront and buy about 10 percent of Juno's shares at $93 each, almost double of Juno's closing price on Monday.

  • In their June 25 lawsuit, Yale University's Global Health Justice Partnership and the Treatment Action Group, an AIDS non-profit, said doctors and patients deserve more information about the "enormously costly" drugs Harvoni and Sovaldi to make informed decisions about whether to use them. The plaintiffs said Gilead ignored its request for the trial data,...

  • AMAG buying Cord Blood Registries for $700 million Monday, 29 Jun 2015 | 10:25 AM ET

    NEW YORK— AMAG Pharmaceuticals Inc. is buying the stem-cell storage company Cord Blood Registry for $700 million from private equity firm GTCR. Waltham, Massachusetts- based AMAG focuses on specialty drugs for maternal health and anemia. Cord Blood Registry had revenue of about $126 million in 2014, the company said.

  • June 29- Vitae Pharmaceuticals Inc said its drug to treat type 2 diabetes in overweight patients did not meet its main goal in a mid-stage study testing it as an add-on therapy. The American Diabetes Association estimates that as many as 1 in 3 American adults will have type 2 diabetes by 2050.. Still, through Friday's close of $15.19, Vitae's shares have almost...

  • June 29- Egalet Corp said data showed its experimental painkiller was less likely to be abused than a form of morphine already being sold. A study showed recreational opioid users did not like and were less prone to snort the company's painkiller, Egalet -001, than MS Contin. Egalet's study results come a week before a panel of experts advising the U.S. Food and...

  • June 29- Vitae Pharmaceuticals Inc said its drug to treat type 2 diabetes in overweight patients did not meet its main goal in a mid-stage study testing it as an add-on therapy. The drug, being co-developed with German drugmaker Boehringer Ingelheim, was tested as an add-on therapy to metformin, a commonly prescribed diabetes drug. Results from another trial...

  • Bristol-Myers to stop new antiviral drug research Thursday, 25 Jun 2015 | 11:08 AM ET

    June 25- Bristol-Myers Squibb said on Thursday that it would stop efforts to find new antiviral drugs and cut 100 related jobs. The company said a research facility is expected to open in Cambridge, Massachusetts in 2018 and that the expansion of an R&D site in San Francisco Bay Area is likely to be completed by 2016.. Bristol-Myers' stock was up marginally at...